Amyloidosis treatment discontinued from clinical trials
A treatment for amyloidosis has been pulled from clinical trials after failing to reach endpoints.
List view / Grid view
News
First treatment for cluster headaches approved in US
The FDA has given its approval to a new injection for cluster headaches which reduce frequency of attacks.
New initiative launched to boost Northern Ireland’s life science industry
The UK’s newest life sciences asset, Health Innovation Research Alliance Northern Ireland (HIRANI), has been launched at a BIO reception.
Ten big pharma companies collaborate on data sharing AI
A new AI project marks the first time 10 pharmaceutical companies have agreed to share data to aid drug discovery.
Global contraceptive pill market to grow 6.6 percent
The global contraceptive pill market is expected to increase to US$8.8 billion by 2024, report finds.
Influenza A vaccine enters Phase IIb trial
Novel influenza A vaccine has been administered to first patients in Phase IIb trial.
Pharmaceutical intermediates market to see growth
The global pharmaceutical intermediates market is likely to see year-on-year growth in 2019, by an estimated 3.6 percent rate.
NICE recommends Prevymis on the NHS after re-evaluation
The National Institute for Health and Care Excellence is recommending MSD’s Prevymis (letermovir) within the NHS.
New partnership established to track drugs using blockchain
Walmart has joined a consortium that’s attempting to build a blockchain for tracking pharmaceutical supply chains.
More effective, safe drugs drive biobetter market growth
The global biobetters market is set to increase due to demand for higher efficacy and safer drugs.
US prescription drug costs soar but price transparency is lacking
A research team from Scripps Research Translational Institute has published revealing figures in relation to drug prices in the US.
Recommendations released to help the EU combat high drug prices
New briefing documents provide policy recommendations to help the EU tackle high medicines prices brought about by market monopolies.
New-generation benchtop mass spectrometer advances quantitative proteomics and translational research
Thermo Scientific Orbitrap Exploris 480 mass spectrometer designed for high-throughput biopharmaceutical and academic research laboratories.
Proposed biosimilar accepted for review by EMA
The EMA has accepted Prestige BioPharma’s marketing application for its trastuzumab biosimilar.
Heritage announces product recall after sterility test failure
Heritage has recalled two of its injectable treatments after microbial growths were found.
